Susquehanna International Group, LLP Compass Pathways PLC Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	BUY	N/A	16,100 Added 25.27%	79,800 $681,000
Q4 2023 Feb 14, 2024	SELL	N/A	-12,700 Reduced 16.62%	63,700 $543,000
Q3 2023 Nov 14, 2023	BUY	N/A	18,000 Added 30.82%	76,400 $652,000
Q2 2023 Aug 11, 2023	BUY	$7.79 - $10.69 $139,441 - $191,351	17,900 Added 44.2%	58,400 $498,000
Q1 2023 May 16, 2023	SELL	$7.32 - $10.85 $2.36 Million - $3.5 Million	-322,800 Reduced 88.85%	40,500 $402,000

Q4 2022 Feb 14, 2023	SELL	$7.84 - $11.68 $1.62 Million - $2.41 Million	-206,200 Reduced 36.21%	363,300 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$10.73 - $20.07 $194,213 - $363,267	-18,100 Reduced 3.08%	569,500 $6.11 Million

134

27.5M

108K

172K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.